A Multinational, Multicenter, Randomized, Parallel-Group, Double-Blind Study to Compare the Efficacy, Tolerability and Safety of Glatiramer Acetate Injection 40mg/ml to That of Glatiramer Acetate Injection 20mg/ml Administered Once Daily by Subcutaneous